1-7 of 7
Theo H. van der Kwast
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate Cancer

Karin G. Hermans, Hetty A. van der Korput, Ronald van Marion, Dennis J. van de Wijngaart, Angelique Ziel-van der Made, Natasja F. Dits, Joost L. Boormans, Theo H. van der Kwast, Herman van Dekken, Chris H. Bangma, Hanneke Korsten, Robert Kraaij, Guido Jenster, Jan Trapman
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7541–7549.
https://doi.org/10.1158/0008-5472.CAN-07-5930
Published: 14 September 2008
View article titled, Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate Cancer
Open the PDF for Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Targeted Biallelic Inactivation of Pten in the Mouse Prostate Leads to Prostate Cancer Accompanied by Increased Epithelial Cell Proliferation but not by Reduced Apoptosis

Xiaoqian Ma, Angelique C. Ziel-van der Made, Binha Autar, Hetty A. van der Korput, Marcel Vermeij, Petra van Duijn, Kitty B. Cleutjens, Ronald de Krijger, Paul Krimpenfort, Anton Berns, Theo H. van der Kwast, Jan Trapman
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5730–5739.
https://doi.org/10.1158/0008-5472.CAN-04-4519
Published: 01 July 2005
View article titled, Targeted Biallelic Inactivation of <em>Pten</em> in the Mouse Prostate Leads to Prostate Cancer Accompanied by Increased Epithelial Cell Proliferation but not by Reduced Apoptosis
Open the PDF for Targeted Biallelic Inactivation of <em>Pten</em> in the Mouse Prostate Leads to Prostate Cancer Accompanied by Increased Epithelial Cell Proliferation but not by Reduced Apoptosis in another window
Journal Articles

Characterization of alternative genetic pathways in the pathogenesis of bladder cancer

Johanna M. M. Van Oers, Peter J. Wild, Elke Rosskopf, Robert Stoehr, Maximilian Burger, Ferdinand Hofstaedter, Theo H. Van der Kwast, Ellen C. Zwarthoff, Arndt Hartmann
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 742.
Published: 01 May 2005
View article titled, Characterization of alternative genetic pathways in the pathogenesis of bladder cancer
Journal Articles

Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation

Lucie C. Kompier, Madelon N. Van der Aa, Latifa Qoubbane, Irene Lurkin, Antoine Van Exsel, Theo H. Van der Kwast, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1347.
Published: 01 May 2005
View article titled, Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation
Journal Articles

FGFR3 and p53 mutations characterize alternative genetic pathways in the pathogenesis of bladder cancer

Ellen C. Zwarthoff, Theo H. Van der Kwast, Andre N. Vis, Wim J. Kirkels, Egbert R. Boeve, Adriaan C. Jobsis, Bas W. Van Rhijn
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 410.
Published: 01 April 2004
View article titled, FGFR3 and p53 mutations characterize alternative genetic pathways in the pathogenesis of bladder cancer
Journal Articles

FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Bas W. G. van Rhijn, Theo H. van der Kwast, André N. Vis, Wim J. Kirkels, Egbert R. Boevé, Adriaan C. Jöbsis, Ellen C. Zwarthoff
Journal: Cancer Research
Cancer Res (2004) 64 (6): 1911–1914.
https://doi.org/10.1158/0008-5472.CAN-03-2421
Published: 16 March 2004
View article titled, <em>FGFR3</em> and <em>P53</em> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma
Open the PDF for <em>FGFR3</em> and <em>P53</em> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma in another window
Journal Articles

High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer

John A. Foekens, Harry A. Peters, Nicolai Grebenchtchikov, Maxime P. Look, Marion E. Meijer-van Gelder, Anneke Geurts-Moespot, Theo H. van der Kwast, C. G. J. (Fred) Sweep, Jan G. M. Klijn
Journal: Cancer Research
Cancer Res (2001) 61 (14): 5407–5414.
Published: 01 July 2001
View article titled, High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer
Open the PDF for High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer in another window